Mylan targets Indian drugs firm
449847
US drugs firm Mylan says it will buy a majority share in India's Matrix, accessing emerging pharmaceutical markets.
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
741854
The generic drugmaker buys an Indian firm to strengthen its long-term prospects.
205093
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) on Monday said its board does not believe discussions with financier Carl Icahn&#39;s about his unsolicited proposal to buy the company are in the company&#39;s best interests.
362567
WASHINGTON An investment firm has told Mylan Laboratories that a proposed acquisition of King Pharmaceuticals is not in the best interests of investors.
695477
Generic drug maker Mylan Laboratories Inc.  said on Friday it expects to raise $993.6 million after pricing a public offering of notes and common shares, with proceeds intended for global operations and potential acquisitions.
727152
New developments are brewing at the pharmaceutical.
741365
PITTSBURGH Mylan Laboratories again reiterated its commitment to the estimated four (B) billion dollar acquisition of brand-name drug maker King Pharmaceuticals despite Wall Street financier Carl Icahn upping his stake in the company.
60257
Mylan Laboratories Inc. MYL.N, which  is trying to acquire King Pharmaceuticals Inc. KG.N, on  Thursday reported its quarterly profit fell by almost 60  percent on a product delay and fierce competition, and it cut  its 2005 forecast.
580086
WASHINGTON (CBS.MW) -- Mylan Laboratories (MYL) , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals (KG) is in the long-term interest of the generic drugmaker and its
489479
Millipore Corp. , a leading supplier of equipment to the drug industry, plans today to open a $50 million research center in Bedford , the centerpiece of a new effort to improve the costly process of making biotechnology drugs.
675205
Billionaire investor Carl Icahn filed a federal lawsuit against Mylan Laboratories Inc. and asset manager Richard C. Perry on Monday, accusing Perry of a vote-buying scheme intended to help Mylan acquire King Pharmaceuticals Inc.
745053
The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles as an Indian company withdrew its medicines last week because it can&#39;t guarantee they are potent enough.
114843
-- Mylan Laboratories Inc. on Wednesday said it was unlikely to complete its &#36;3.37 billion acquisition of King Pharmaceuticals Inc. at the current price because of King's need to restate earnings.
43938
Northern Irish drug maker Warner Chilcott says it has received an approach from a second party interested in bidding for the company, raising the prospect of a 1.5-billion-pound takeover battle.
550625
Financier Carl Icahn on Friday  offered to buy the shares of generic drugmaker Mylan  Laboratories MYL.N that he does not already own for $4.9  billion, or $20 a share, according to a government filing.
357770
Veteran financier Carl Icahn said he and a group of investors are willing to buy Mylan Laboratories Inc. for $20 per share, according to a Friday filing with the Securities and Exchange Commission.